<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Icodextrin</id>
	<title>Icodextrin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://debianws.lexgopc.com/wiki143/index.php?action=history&amp;feed=atom&amp;title=Icodextrin"/>
	<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Icodextrin&amp;action=history"/>
	<updated>2026-05-04T20:43:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.1</generator>
	<entry>
		<id>http://debianws.lexgopc.com/wiki143/index.php?title=Icodextrin&amp;diff=3964844&amp;oldid=prev</id>
		<title>imported&gt;GreenC bot: Move 1 url. Wayback Medic 2.5 per WP:URLREQ#fda.gov</title>
		<link rel="alternate" type="text/html" href="http://debianws.lexgopc.com/wiki143/index.php?title=Icodextrin&amp;diff=3964844&amp;oldid=prev"/>
		<updated>2025-05-29T21:08:09Z</updated>

		<summary type="html">&lt;p&gt;Move 1 url. &lt;a href=&quot;/wiki143/index.php?title=User:GreenC/WaybackMedic_2.5&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;User:GreenC/WaybackMedic 2.5 (page does not exist)&quot;&gt;Wayback Medic 2.5&lt;/a&gt; per &lt;a href=&quot;/wiki143/index.php?title=WP:URLREQ&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:URLREQ (page does not exist)&quot;&gt;WP:URLREQ#fda.gov&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{short description|Pharmaceutical drug}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| Watchedfields = changed&lt;br /&gt;
| verifiedrevid = 461936512&lt;br /&gt;
| IUPAC_name =  &lt;br /&gt;
| image =Dextrin_skeletal.svg&lt;br /&gt;
&amp;lt;!-- Clinical data --&amp;gt;&lt;br /&gt;
| tradename =  &lt;br /&gt;
| Drugs.com = {{drugs.com|international|icodextrin}}&lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = C&lt;br /&gt;
| legal_AU = &amp;lt;!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --&amp;gt;&lt;br /&gt;
| legal_CA = &amp;lt;!-- Schedule I, II, III, IV, V, VI, VII, VIII --&amp;gt;&lt;br /&gt;
| legal_UK = &amp;lt;!-- GSL, P, POM, CD, or Class A, B, C --&amp;gt;&lt;br /&gt;
| legal_US = &amp;lt;!-- OTC / Rx-only / Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
| legal_status = Rx&lt;br /&gt;
| routes_of_administration = [[Intraperitoneal]]&lt;br /&gt;
&amp;lt;!-- Pharmacokinetic data --&amp;gt;&lt;br /&gt;
| bioavailability = 40% in 12 hours&lt;br /&gt;
| protein_bound =  &lt;br /&gt;
| metabolism = [[Alpha-amylase]]&lt;br /&gt;
| elimination_half-life =  &lt;br /&gt;
| excretion = [[Renal]]&lt;br /&gt;
&amp;lt;!-- Identifiers --&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|??}}&lt;br /&gt;
| CAS_number = 337376-15-5&lt;br /&gt;
| ATC_prefix = B05&lt;br /&gt;
| ATC_suffix = DA&lt;br /&gt;
| ATC_supplemental =  &lt;br /&gt;
| PubChemSubstance = 17397419&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| DrugBank = DB00702&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = 2NX48Z0A9G&lt;br /&gt;
| KEGG_Ref = {{keggcite|changed|kegg}}&lt;br /&gt;
| KEGG = D03266&lt;br /&gt;
| ChEMBL_Ref = {{ebicite|changed|EBI}}&lt;br /&gt;
| ChEMBL = 1201472&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}&lt;br /&gt;
| ChemSpiderID = none&lt;br /&gt;
&amp;lt;!-- Chemical data --&amp;gt;&lt;br /&gt;
| chemical_formula = (C&amp;lt;sub&amp;gt;6&amp;lt;/sub&amp;gt;H&amp;lt;sub&amp;gt;10&amp;lt;/sub&amp;gt;O&amp;lt;sub&amp;gt;5&amp;lt;/sub&amp;gt;)&amp;lt;sub&amp;gt;n&amp;lt;/sub&amp;gt;&lt;br /&gt;
| molecular_weight = 13–19 kg/mol&lt;br /&gt;
| smiles =  &lt;br /&gt;
| synonyms =  &lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Icodextrin&amp;#039;&amp;#039;&amp;#039; ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]) is a [[colloid]] [[osmotic]] agent, derived from [[maltodextrin]],&amp;lt;ref name=&amp;quot;maltod&amp;quot;&amp;gt;{{cite book |title=Clinical evidence, Issue 14 |pages=1046 |author=American College of Physicians--American Society of Internal Medicine |year=2005 |publisher=BMJ Pub. Group}}&amp;lt;/ref&amp;gt; used in form of an [[aqueous]] solution for [[peritoneal dialysis]] under the trade name &amp;#039;&amp;#039;&amp;#039;Extraneal&amp;#039;&amp;#039;&amp;#039;,&amp;lt;ref name=&amp;quot;RxList&amp;quot; /&amp;gt; and after gynecological [[laparoscopic]] surgery for the reduction of post-surgical [[adhesion (medicine)|adhesion]]s (fibrous bands that form between tissues and organs) under the trade name &amp;#039;&amp;#039;&amp;#039;Adept&amp;#039;&amp;#039;&amp;#039;.&amp;lt;ref name=&amp;quot;FDA&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
Icodextrin is a [[starch]]-derived, branched, water-soluble [[glucose]] [[polymer]] linked by α-(1→4) and less than 10% α-(1→6) [[glycosidic bond]]s, making it a type of [[dextrin]]. Its weight-average molecular weight is between 13,000 and 19,000 [[Dalton (unit)|dalton]]s and its number-average molecular weight between 5,000 and 6,500 daltons. The substance is a white to off-white solid, and the solution is clear and colourless to pale yellow.&amp;lt;ref name=&amp;quot;FDA&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Mechanism of action==&lt;br /&gt;
The osmotic activity of icodextrin keeps the solution inside the [[peritoneum]] for three to four days, separating tissues and thus reducing adhesion between them when [[fibrin]] is formed after a surgery. In other words, the tissues are kept from gluing together.&amp;lt;ref name=&amp;quot;FDA&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:DP branchement.svg|thumb|left|upright|[[Peritoneal dialysis]]]]&lt;br /&gt;
When used for peritoneal dialysis, the icodextrin solution absorbs waste products from the blood, and is removed from the peritoneum after a few hours together with the waste.&amp;lt;ref&amp;gt;{{cite journal | vauthors = Frampton JE, Plosker GL | title = Icodextrin: a review of its use in peritoneal dialysis | journal = Drugs | volume = 63 | issue = 19 | pages = 2079–105 | year = 2003 | pmid = 12962523 | doi = 10.2165/00003495-200363190-00011 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Pharmacokinetics==&lt;br /&gt;
Icodextrin is not significantly metabolised inside the peritoneum. Instead, it is absorbed slowly (40% after 12 hours) into the bloodstream via the [[lymph vessel]]s. There it is broken down into [[oligosaccharide]]s by the enzyme [[alpha-amylase]]. In patients with intact kidney function, both icodextrin and its fragments are excreted via the kidney by [[glomerular filtration]].&amp;lt;ref name=&amp;quot;RxList&amp;quot;&amp;gt;{{cite web | work = RxList.com | url = http://www.rxlist.com/extraneal-drug.htm | title = Extraneal }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;FDA&amp;quot;&amp;gt;{{cite web | work = FDA | url = https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050011c.pdf | title = Adept (4% Icodextrin) Adhesion Reduction Solution }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
Icodextrin is contraindicated in patients with cornstarch allergy, [[maltose]] or [[isomaltose]] intolerance, [[glycogen storage disease]], or severe [[lactic acidosis]].&amp;lt;ref name=&amp;quot;Drugs.com&amp;quot;&amp;gt;{{cite web | work = Drugs.com | url = https://www.drugs.com/pro/extraneal.html | title = Extraneal }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Adverse effects==&lt;br /&gt;
Adverse effects include [[peritonitis]], [[respiratory infection]], [[hypertension]] (high blood pressure), [[rash]]es, and headache. Of these side effects, only hypertension and rashes occurred significantly more often than under glucose solution; the other events seem to be related to peritoneal dialysis in general.&amp;lt;ref name=&amp;quot;Drugs.com&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Interactions ==&lt;br /&gt;
&lt;br /&gt;
Icodextrin can mimic increased [[blood glucose]] levels, depending on the used testing system. Specifically, glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase (GDO) based tests can erroneously show high blood glucose in patients that have been treated with icodextrin.&amp;lt;ref name=&amp;quot;Drugs.com&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
{{Blood substitutes and perfusion solutions}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Renal dialysis]]&lt;br /&gt;
[[Category:Polysaccharides]]&lt;/div&gt;</summary>
		<author><name>imported&gt;GreenC bot</name></author>
	</entry>
</feed>